MILLENNIUM MANAGEMENT LLC - BIOSCRIP INC ownership

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2019$50,000
-92.8%
19,111
-94.5%
0.00%
-100.0%
Q1 2019$695,000
-90.3%
347,631
-82.7%
0.00%
-90.9%
Q4 2018$7,171,000
+1.7%
2,008,723
-11.7%
0.01%
+22.2%
Q3 2018$7,051,000
-10.3%
2,274,432
-15.2%
0.01%
-10.0%
Q2 2018$7,861,000
+31.7%
2,682,984
+10.6%
0.01%
+25.0%
Q1 2018$5,967,000
+267.2%
2,425,782
+334.4%
0.01%
+300.0%
Q4 2017$1,625,000
-79.8%
558,367
-80.9%
0.00%
-83.3%
Q3 2017$8,046,000
+359.2%
2,925,882
+353.5%
0.01%
+300.0%
Q2 2017$1,752,000
+191.0%
645,123
+82.1%
0.00%
+200.0%
Q1 2017$602,000
-4.7%
354,313
-41.7%
0.00%0.0%
Q4 2016$632,000
+409.7%
607,832
+1313.0%
0.00%
Q3 2016$124,000
-43.4%
43,018
-49.8%
0.00%
-100.0%
Q2 2016$219,000
-54.2%
85,698
-61.6%
0.00%0.0%
Q1 2016$478,000
-56.2%
223,322
-64.2%
0.00%
-50.0%
Q4 2015$1,092,000
+92.9%
624,041
+106.3%
0.00%
+100.0%
Q3 2015$566,000
-93.2%
302,486
-86.9%
0.00%
-93.8%
Q2 2015$8,357,000
-1.9%
2,302,337
+19.8%
0.02%0.0%
Q1 2015$8,516,000
-35.1%
1,922,321
+2.4%
0.02%
-42.9%
Q4 2014$13,120,000
+0.7%
1,876,962
-0.5%
0.03%
-15.2%
Q3 2014$13,029,000
-2.8%
1,885,462
+17.3%
0.03%
-10.8%
Q2 2014$13,405,000
-9.8%
1,607,309
-24.5%
0.04%
-14.0%
Q1 2014$14,854,000
+3.8%
2,128,104
+10.1%
0.04%
-4.4%
Q4 2013$14,309,000
+249.3%
1,933,688
+314.4%
0.04%
+246.2%
Q3 2013$4,097,000466,6280.01%
Other shareholders
BIOSCRIP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Coliseum Capital Management, LLC 5,622,410$5,847,0002.64%
NORTH TIDE CAPITAL, LLC 8,500,000$8,840,0001.51%
WYNNEFIELD CAPITAL INC 3,700,000$3,848,0001.39%
Alta Fundamental Advisers LLC 2,330,774$2,424,0001.20%
ARDSLEY ADVISORY PARTNERS LP 6,350,000$6,604,0001.09%
Camber Capital Management LP 10,180,000$10,587,0000.55%
PERKINS CAPITAL MANAGEMENT INC 298,000$310,0000.34%
Hawk Ridge Capital Management 340,429$354,0000.18%
Eidelman Virant Capital 220,000$228,0000.13%
ROANOKE ASSET MANAGEMENT CORP/ NY 227,280$236,0000.11%
View complete list of BIOSCRIP INC shareholders